300006.SZ
Chongqing Lummy Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.09
−3.42%Margins
Gross margin
55.3%
EBITDA margin
-12.9%
EBIT margin
-19.5%
Net margin
-17.9%
FCF margin
0.2%
-7.8%
Return on equity
-5.2%
Return on assets
-7.4%
Return on invested capital
0.29x
Asset turnover
CNY 34.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026